Lista de obras - Sophie Erhardt - Dominio Público Uruguay

A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality

artículo científico publicado en 2014

Activation of brain interleukin-1beta in schizophrenia.

artículo científico publicado en 2009

Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.

artículo científico publicado en 1999

Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms

artículo científico publicado en 2005

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis

artículo científico publicado en 2007

Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct.

artículo científico publicado en 2010

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

artículo científico publicado en 2012

Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid

artículo científico publicado en 2013

CSF biomarkers in suicide attempters--a principal component analysis.

artículo científico publicado en 2010

CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis

artículo científico publicado en 2012

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia

artículo científico publicado en 2022

Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors

artículo científico publicado en 2006

Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites

scientific article published on 01 February 2007

Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder

artículo científico publicado en 2012

Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area

artículo científico publicado en 2008

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

artículo científico publicado en 2004

Connecting inflammation with glutamate agonism in suicidality.

artículo científico publicado en 2012

Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid

artículo científico publicado en 2006

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia

artículo científico publicado en 2008

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

artículo científico publicado en 2005

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder

artículo científico publicado en 2010

Endogenous kynurenic acid disrupts prepulse inhibition

artículo científico publicado en 2004

Excitation of nigral dopamine neurons by the GABA(A) receptor agonist muscimol is mediated via release of glutamate

artículo científico publicado en 2000

Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.

artículo científico publicado en 2002

GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo

artículo científico publicado en 2002

Imbalanced kynurenine pathway in schizophrenia

artículo científico publicado en 2014

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

artículo científico publicado en 2015

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

artículo científico publicado en 2010

Increased peripheral levels of TARC/CCL17 in first episode psychosis patients

artículo científico publicado en 2019

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

artículo científico publicado en 2002

Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors

artículo científico publicado en 1998

Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid

artículo científico publicado en 2003

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

artículo científico publicado en 2009

Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies

artículo científico publicado en 2014

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

artículo científico publicado en 2001

Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study

Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls

artículo científico publicado en 2012

Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in Reference Memory in Mice

artículo científico publicado en 2019

Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice

artículo científico publicado en 2009

Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid

artículo científico publicado en 2000

Oxytocin increases locus coeruleus alpha 2-adrenoreceptor responsiveness in rats

artículo científico publicado en 1998

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

artículo científico publicado en 2001

Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders

artículo científico publicado en 2009

Prenatal dexamethasone impairs behavior and the activation of the BDNF exon IV promoter in the paraventricular nucleus in adult offspring

artículo científico publicado en 2008

Quantification of Plasma Kynurenine Metabolites Following One Bout of Sprint Interval Exercise

artículo científico publicado en 2020

Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

artículo científico publicado en 2016

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression

artículo científico publicado en 2014

Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.

artículo científico publicado en 2011

Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons

artículo científico publicado en 2005

The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression

artículo científico publicado en 2013

The anaesthetic agent propofol interacts with GABA(B)-receptors: an electrophysiological study in rat.

artículo científico publicado en 2003

The kynurenic acid hypothesis of schizophrenia

artículo científico publicado en 2007

The kynurenine pathway in schizophrenia and bipolar disorder.

artículo científico publicado en 2016

Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid

artículo científico publicado en 2019

Lista de obras de Sophie Erhardt

A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality

Activation of brain interleukin-1beta in schizophrenia.

Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.

Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis

Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct.

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid

CSF biomarkers in suicide attempters--a principal component analysis.

CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia

Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors

Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites

Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder

Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

Connecting inflammation with glutamate agonism in suicidality.

Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder

Endogenous kynurenic acid disrupts prepulse inhibition

Excitation of nigral dopamine neurons by the GABA(A) receptor agonist muscimol is mediated via release of glutamate

Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.

GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo

Imbalanced kynurenine pathway in schizophrenia

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

Increased peripheral levels of TARC/CCL17 in first episode psychosis patients

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors

Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study

Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls

Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in Reference Memory in Mice

Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice

Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid

Oxytocin increases locus coeruleus alpha 2-adrenoreceptor responsiveness in rats

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders

Prenatal dexamethasone impairs behavior and the activation of the BDNF exon IV promoter in the paraventricular nucleus in adult offspring

Quantification of Plasma Kynurenine Metabolites Following One Bout of Sprint Interval Exercise

Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression

Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.

Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons

The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression

The anaesthetic agent propofol interacts with GABA(B)-receptors: an electrophysiological study in rat.

The kynurenic acid hypothesis of schizophrenia

The kynurenine pathway in schizophrenia and bipolar disorder.

Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid